LGALS9 and neoplasm: A noteworthy study demonstrated that Gal-9-enriched exosomes derived from GB impair the function of dendritic cells (DCs) and CD8+ T cells by binding to TIM-3, thereby facilitating tumor progression (Wang M. et al., 2020).